Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension (Q51587900)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 1995

edit

Language	Label	Description	Also known as
English	Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension	scientific article published in June 1995

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

title

Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

main subject

arterial hypertension

0 references

author

Ralph A. DeFronzo

series ordinal

5

object named as

DeFronzo RA

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

author name string

Giordano M

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

Matsuda M

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

Sanders L

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

Canessa ML

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

language of work or name

English

0 references

publication date

1 June 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Diabetes

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

volume

44

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

page(s)

665-671

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

Identifiers

DOI

10.2337/DIAB.44.6.665

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

PubMed publication ID

7789631

1 reference

stated in

Europe PubMed Central

PubMed publication ID

7789631

retrieved

7 April 2018

reference URL

http://europepmc.org/abstract/MED/7789631

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51587900&oldid=2277628772"